Stem cells could cut high rate of cornea transplant rejection
Corneal eye disease is the fourth most common cause of blindness in the world and affects more than 10 million people worldwide. New research from NUI Galway has found that transplant rejection rates could be reduced to as low as 10% by administering a stem cell grown from the bone marrow of adult donors.
Although 100,000 people worldwide undergo cornea transplants each year, about 30% are unsuccessful due to rejection by the patient’s own immune system.
